China Medical to Announce Third Quarter Unaudited Financial Results for the Fiscal Year Ending March 31, 2007 on February 27, 2007.BEIJING -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED CMED Coordinated Medical Emergency Direction CMED Central Massachusetts Emergency Dispatch ), a leading China-based medical device company that develops, manufactures and markets tumor tumor: see neoplasm. therapy systems and advanced in-vitro diagnostic systems, announced that it will release its unaudited financial results for the third quarter of 2006 ("3Q FY 2006") at 6:00 a.m., Eastern Time, on February 27, 2007. The Company will host a conference call that day at 8:00 a.m., Eastern Time (9:00 p.m., Beijing/Hong Kong time), to discuss the results. The Company's 2006 fiscal year ends March 31, 2007, which makes the quarter ended December 31, 2006, the Company's third quarter. Conference Call Mr. Sam Tsang, Chief Financial Officer, Mr. Charles Zhu, Vice President, and Ms. Winnie Fan, Senior Manager of Finance and Investor Relations Investor relations The process by which the corporation communicates with its investors. will discuss the results and take questions following the earnings announcement. The dial-in details for the live conference call are as follows:
- U.S. Toll Free Number 1 866 510 0705
- International dial-in number 1 617 597 5363
Passcode CMEDCALL.
A live webcast of the conference call will be available on the investor relations section of the Company's website at: www.chinameditech.com. A replay of the webcast will be available for one month on this website. A telephone replay of the call will be available after the conclusion of the conference call through February 28, 2007 10:00 a.m. Eastern Time. The dial-in details for the replay are as follows:
- U.S. Toll Free Number 1 888 286 8010
- International dial-in number 1 617 801 6888
Passcode 93175957.
About China Medical Technologies, Inc. China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets products using high intensity focused ultrasound HIFU (high intensity focused ultrasound) (sometimes FUS or HIFUS) is a highly precise medical procedure using high-intensity focused ultrasound to heat and destroy pathogenic tissue rapidly. for the treatment of solid cancers and benign tumors benign tumor n. A tumor that does not metastasize or invade and destroy adjacent normal tissue. Benign tumor An abnormal proliferation of cells that does not spread to other parts of the body. and advanced in-vitro diagnostics products using enhanced chemiluminescence chemiluminescence /chemi·lu·mi·nes·cence/ (kem?i-loo?mi-nes´ens) luminescence produced by direct transformation of chemical energy into light energy. immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. technology, to detect and monitor various diseases and disorders. For more information, please visit our website at www.chinameditech.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion